Cite

HARVARD Citation

    Liu, Z. et al. (2021). Bone marrow-derived mesenchymal stem cells inhibit CD8+ T cell immune responses via PD-1/PD-L1 pathway in multiple myeloma. Clinical and experimental immunology. pp. 53-62. [Online]. 
  
Back to record